Consolidated Financial Results
for the Fiscal Year Ended June 30, 2021
[Japanese GAAP]
August 10, 2021
Company name: OLBA HEALTHCARE HOLDINGS, Inc.
Stock exchange listing: Tokyo Stock Exchange
Code number: 2689
URL: https://www.olba.co.jp/
Representative: Yohei Maeshima, President CEO
Contact: Nobuharu Murata, Managing Director and General Manager, Administrative Department
Phone: +81-86-236-1115
Scheduled date of general meeting of shareholders: September 22, 2021
Scheduled date of commencing dividend payments: September 24, 2021
Scheduled date of filing securities report: September 24, 2021Availability of supplementary briefing material on financial results: Unavailable
Schedule of financial results briefing session: Scheduled (for securities analysts)(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Fiscal Year Ended June 30, 2021 (July 1, 2020 to June 30, 2021)(1) Consolidated Operating Results(% indicates changes from the previous year.)
Net income
Net sales
Operating income
Ordinary income
attributable toowners of parent
Fiscal year ended
Million yen%
Million yen%
Million yen%
Million yen%
112,976
1,54066.2
1,542
70.3
989 203.1
June 30, 2021
4.7
107,896927(28.8)
905(30.9)
326(57.9)
June 30, 2020
0.4
(Note) Comprehensive income: Fiscal year ended June 30, 2021: ¥1,128 million [314.1 %]Fiscal year ended June 30, 2020: ¥272 million [(52.9) %]Basic earnings
per share

Diluted earnings
per share

Yen

Yen

Fiscal year ended
June 30, 2021
June 30, 2020

Return on equity––

162.6656.76(2) Consolidated Financial Position
Total assets

Net assets

Million yen

36,562As of June 30, 2021
33,683As of June 30, 2020
(Reference) Equity: As of June 30, 2021: ¥8,131 million
As of June 30, 2020: ¥7,281 million

Ratio of ordinary
income to total
assetsRatio ofoperating income
to net sales

%%%

12.8
4.7

4.4
2.7

1.4
0.9

Net assets per share

Equity ratio

Million yen%

Yen

8,131
7,281

22.2
21.6

1,336.91
1,197.17

Cash flows fromfinancing activities

Cash and cash
equivalents at endof period(3) Consolidated Cash Flows
Cash flows fromoperating activities
As of June 30, 2021
As of June 30, 2020

Cash flows frominvesting activities

Million yen

Million yen

Million yen

Million yen

3,126862

(630)
(496)

(2,262)
439

2,110
1,877

2. Dividends
Annual dividends
1st2nd3rdquarter-end quarter-end quarter-end Year-end
Fiscal year ended
June 30, 2020
Fiscal year ended
June 30, 2021
Fiscal year ending
June 30, 2022
(Forecast)Total
annualdividends

Total

Payoutratio%%

278

79.3

3.8

309

30.7

3.9

Yen Million yen

Yen

Yen

Yen

Yen

–

0.00

–

45.00

45.00

–

0.00

–

50.00

50.00

–

0.00

–

50.00

50.00

Ratio ofdividends toshareholders’equity–3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2022 (July 1, 2021 to June 30, 2022)(% indicates changes from the previous corresponding period.)
Net sales
Million yen%

Operating income

Ordinary income

Million yen

Million yen%

Net income
attributable toowners of parent% Million yen

Basic earnings
per share%

Yen

51,774 –
564 (9.0)
571 (7.1)
360 (7.3)
59.29
First half
105,049 –1,597 3.7
1,615 4.7
1,052
6.4
173.01
Full year(Note) Effective the beginning of the fiscal year ending June 30, 2022, the Company will begin applying the AccountingStandard for Revenue Recognition (ASBJ Statement No. 29) and other standards. Those standards have beenreflected in the figures of the consolidated financial results forecast above, so the changes in net sales from theprevious corresponding period are not presented. Meanwhile, operating income, ordinary income, and net income
attributable to owners of parent will not be affected by the application of those standards, and their changes arepresented above.
Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting inchanges in scope of consolidation): None
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)(2) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: None
2) Changes in accounting policies other than 1) above: None
3) Changes in accounting estimates: None
4) Retrospective restatement: None
(3) Total number of issued shares (common stock)1) Total number of issued shares at the end of the period (including treasury stock):
June 30, 2021: 6,250,000 shares
June 30, 2020: 6,250,000 shares2) Total number of treasury stock at the end of the period:
June 30, 2021: 167,676 shares
June 30, 2020: 167,605 shares
3) Average number of shares during the period:
June 30, 2021: 6,082,368 shares
June 30, 2020: 5,750,333 shares
As of the end of the consolidated fiscal year ended June 30, 2021, 116,600 shares of the Company’s stock held by
the Board Benefit Trust were included in treasury stock.

(Reference) Summary of non-consolidated financial results
Non-consolidated Financial Results for the Fiscal Year Ended June 30, 2021 (July 1, 2020 to June 30, 2021)(1) Non-consolidated Operating Results(% indicates changes from the previous corresponding period.)
Net sales
Operating income
Ordinary income
Net income
Fiscal year ended
Million yen%
Million yen%
Million yen%
Million yen%
June 30, 2021
1,670
6.2
484
4.0
476
99.7
384
–
(1.8)
3.7
238
(46.6)(228)–June 30, 2020
1,573465
Basic earnings
per share

Fiscal year ended
June 30, 2021
June 30, 2020

Dilutedearnings
Yen

Yen

63.17(39.73)––(2) Non-consolidated Financial Position
Total assets

Net assets

Million yen

As of June 30, 2021
7,838
As of June 30, 2020
8,781
(Reference) Equity: As of June 30, 2021: ¥4,099 million
As of June 30, 2020: ¥3,993 million

Equity ratio

Net assets per share

Million yen%

Yen

4,099
3,993

52.3
45.5

673.94656.64* These financial results are outside the scope of audit procedures conducted by a certified public accountant or audit
corporation.
* Explanation of the proper use of financial results forecast and other notes• The figures forecasted above were prepared based on information that is available as of the date ofpublication of this document. Actual results may differ from these forecast figures due to various factors
in the future.
• The Company changed its name from KAWANISHI HOLDINGS, INC. to OLBA HEALTHCAREHOLDINGS, Inc. on January 1, 2021.